Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation, today notes that its portfolio company Harpoon Therapeutics, Inc. ("Harpoon") has filed a registration statement on Form S-1 with the U.S. Securities and Exchange...
from PR Newswire: https://prn.to/2EU9QjL
No comments:
Post a Comment